- About
Us - Dialysis
Products - Dialysis
Services - Lab
Services - Renal
Pharmaceuticals - Research
- Physician
Services - Inpatient
Services - Investor
Relations - Newsroom
- Career
Opportunities
Years
Search Newsroom
Press Releases
5/8/13 1:05 pm EDT
Modern
Healthcare magazine presented one of its coveted “Spirit of
Excellence” awards this week to Fresenius
Medical Care North America (FMCNA), the nation’s leading network of dialysis
facilities, in recognition of the company’s innovative new social
work program, which has increased patients’ adherence to dialysis
treatments by addressing quality of life issues. FMCNA was selected as
winner of the “Team Spirit” award for its ability to more...
4/8/13 7:00 am EDT
Heritage California ACO (HCACO), a Pioneer Accountable Care Organization
and affiliate of Heritage Provider Network, and Fresenius Medical Care
(NYSE: FMS), North America’s largest provider of kidney care services,
announced an agreement today to provide integrated health care
management for HCACO’s patients who have End Stage Renal Disease (ESRD).
The agreement supports a population health program that allows Fresenius
Medical Care to work with more...
3/14/13 9:00 am EDT
With high
blood pressure now the second most common cause of chronic kidney
disease (CKD) in the United States (behind only diabetes), Fresenius
Medical Care North America (FMCNA) wants people to know that
controlling their blood pressure can slow the progression of CKD, and
help prevent heart disease and strokes in those who are on dialysis.
This March during National
Kidney Month, FMCNA, the nation’s leading network of dialysis more...
3/7/13 11:00 am EST
Chronic
kidney disease (CKD) affects millions of Americans and requires
about 400,000 of those whose kidneys have failed to rely on
life-sustaining dialysis
treatments to clean waste products and remove extra fluids from their
blood. Kidney failure is also often associated with heart disease,
diabetes, high blood pressure and other ailments – but despite these
conditions, incorporating a healthy lifestyle can help dialysis patients more...
2/20/13 1:45 pm EST
In recognition of National
Kidney Month this March, Chef
Aaron McCargo, Jr. is taking his kidney-friendly recipes and
signature “flavor of bold” cuisine on the road to several U.S. cities.
Organized and sponsored by Fresenius
Medical Care North America (FMCNA), this four-city tour is intended
to call attention to how diets featuring fresh, flavorful ingredients
can be healthy for patients on dialysis, as well as tasty, affordable, more...
2/7/13 4:53 pm EST
In anticipation of Winter Storm Nemo, Fresenius
Medical Care North America (FMCNA), the nation’s leading network of dialysis
facilities, has activated its Emergency
Response Team to begin implementing plans to ensure continued
patient care throughout areas in the Northeast which may be affected by
the storm.
The Fresenius Medical Care Disaster Response Team, assisted by
divisional, technical and regional employees, works closely more...
12/20/12 9:00 am EST
While daytime dialysis treatments are a fact of life for many thousands
of people with kidney failure, a growing number of dialysis patients are
discovering that dialyzing overnight lets them keep their days free for
work, family or other activities.
Fresenius
Medical Care North America (FMCNA), the nation’s leading network of dialysis
facilities, has established more than 140 in-center nocturnal, or
nighttime, dialysis more...
11/6/12 5:23 pm EST
Although more than 100 Fresenius
Medical Care North America (FMCNA) clinics in the mid-Atlantic
region were affected by Hurricane Sandy last week, all but one have now
resumed operations.
FMCNA, the nation’s leading network of dialysis
facilities, is pleased to report that all of its patients and
employees are now accounted for and safe, even though many were
personally affected by the storm, which caused power outages, more...
10/26/12 5:10 pm EDT
In anticipation of Hurricane Sandy, Fresenius
Medical Care North America (FMCNA), the nation’s leading network of dialysis
facilities, has activated its Emergency
Response Team to begin implementing plans to ensure continued
patient care across the U.S. Northeast and Mid-Atlantic regions, which
may be affected by the storm.
The Fresenius Medical Care Disaster Response Team, assisted by
divisional, technical and regional employees more...
7/26/12 9:28 am EDT
When severe thunderstorms left a trail of property destruction and power
outages stretching from Illinois to New Jersey on June 29, Fresenius
Medical Care North America (FMCNA) immediately activated its
Emergency Task Force, which initiated disaster response plans to assure
uninterrupted service for patients at 45 affected clinics across the
region. FMCNA, which operates the nation’s leading network of dialysis
facilities, takes special more...
12/23/11 2:45 pm EST
The nation’s leading network of dialysis
facilities is recognizing more than 25 patients across the nation
who will be 100 years or older in 2012 and are still leading healthy,
fulfilling lives without their kidney function. A healthy lifestyle has
helped these dialysis patients reach the century mark in their lives.
Modern dialysis
treatments are giving patients with kidney
failure a better chance than ever to maintain a healthy more...
11/16/11 11:31 am EST
Fresenius
Medical Care (NYSE: FMS), the world’s largest provider of dialysis
products and services, announced that Franklin W. Maddux, M.D., FACP,
has been appointed Chief Medical Officer (CMO) for Fresenius Medical
Care North America (FMCNA), effective December 12, 2011. In this role he
will also be responsible for Clinical and Scientific Affairs.
Dr. Maddux will report to Rice Powell, Chief Executive Officer of
Fresenius Medical more...
11/10/11 8:00 am EST
BAD HOMBURG, Germany--(BUSINESS WIRE)--Fresenius Medical Care AG & Co. KGaA (“the company” or “Fresenius
Medical Care”; Frankfurt Stock Exchange: FME / New York Stock Exchange:
FMS), the world’s largest provider of dialysis products and services,
today introduced the 2008K@home, a hemodialysis system for use at the
patient’s home, at the American Society of Nephrology’s Kidney Week 2011
meeting in Philadelphia, USA. The 2008K@home machine is built on the more...
11/9/11 8:09 am EST
PHILADELPHIA--(BUSINESS WIRE)--At the American Society of Nephrology’s Kidney Week 2011, Fresenius
Medical Care (NYSE: FMS), the world’s largest provider of dialysis
products and services, announced that it received U.S. Food and Drug
Administration 510 (K) clearance to extend improved touch screen
navigation on its most advanced hemodialysis delivery system, the 2008T.
Effective immediately, all newly produced 2008T machines with Fresenius
Clinical more...
7/29/11 9:00 am EDT
People on kidney dialysis need life-sustaining therapy typically three
days a week, so many patients resist the urge to travel because of their
uncertainty about their treatments away from home. Today it’s easy and
safe to arrange for dialysis at a clinic near their destination.
Summer is quickly coming to an end and dialysis patients may want to
squeeze in a trip to Cape Cod, the Jersey shore, or the Carolinas before
the season is over more...
7/1/11 9:33 am EDT
BAD HOMBURG, Germany--(BUSINESS WIRE)--Fresenius Medical Care AG & Co. KGaA (“the Company” or “Fresenius
Medical Care”; Frankfurt Stock Exchange: FME / New York Stock Exchange:
FMS), the world’s largest provider of dialysis products and services,
today announced that it has completed the acquisition of Euromedic’s
dialysis service business effective June 30, 2011. This follows final
regulatory approvals by the relevant antitrust authorities1 more...
6/29/11 9:30 am EDT
In the heat of the summer, most people make a point to drink more to
stay hydrated. But for dialysis patients, too much fluid can be
life-threatening. Fresenius
Medical Care North America (FMCNA), the nation's leading network of
dialysis facilities, reminds patients to closely monitor their fluid
intake, and offers tips on how to quench their thirst without
jeopardizing their health during the hot summer months.
The kidneys more...
5/31/11 11:30 am EDT
During natural disasters, people expect FEMA and the Red Cross to
mobilize at a moment's notice to help those in need. However, did you
know that a healthcare company that provides life-sustaining care to the
chronically ill is doing the same? Kidney dialysis clinics and patients
need to be prepared for worst-case scenarios because dialysis patients
need treatment every two to three days. Getting treatments can be a
matter of life or death for more...
5/4/11 1:35 am EDT
Fresenius Medical Care AG & Co. KGaA (NYSE: FMS) (FWB: FME):
1st
Quarter 2011 Summary:
Net revenue more...
4/7/11 11:00 am EDT
Diabetes is the single leading cause of kidney
failure in the U.S., accounting for about 44 percent of the people
who start treatment for kidney failure each year. To help raise
awareness of the links between diabetes and chronic
kidney disease (CKD), Fresenius
Medical Care North America (FMCNA), the nation’s leading network of dialysis
facilities, will sponsor the American
Diabetes Association (the Association) EXPO Atlanta, to be held more...
3/17/11 12:55 pm EDT
WALTHAM, Mass.--(BUSINESS WIRE)--Fresenius Medical Care (NYSE: FMS), the world’s leading company devoted
to renal therapy, said today that the U.S. Agency for Healthcare
Research and Quality officially recognized the company’s Patient Safety
Organization (PSO.) The certification by the U.S. Secretary of the
Department of Health and Human Services, the first for a dialysis
organization, furthers Fresenius Medical Care’s mission of continuously
improving more...
3/17/11 12:01 pm EDT
BAD HOMBURG, Germany--(BUSINESS WIRE)--Fresenius Medical Care AG & Co. KGaA (“the company” or “Fresenius
Medical Care”), the world’s largest provider of dialysis products and
services, announced today that the U.S. Agency for Healthcare Research
and Quality (AHRQ) officially recognized the company’s Patient Safety
Organization (PSO). The certification by the U.S. Secretary of the
Department of Health and Human Services, the first for a dialysis more...
3/16/11 9:34 am EDT
Research has shown that regular exercise can be helpful in managing chronic
kidney disease (CKD), and can limit its harmful effects on the body.
During National
Kidney Month this March, Fresenius
Medical Care North America (FMCNA), the nation’s leading network of
dialysis facilities, is urging the growing population of people on
dialysis to exercise frequently, which can improve their day-to-day
energy and quality of life more...
3/10/11 9:00 am EST
Diabetes and high blood pressure are the two leading causes
of chronic kidney disease (CKD), a health problem that is growing at
an alarming rate in the United States. There are 26 million Americans
who have CKD,
and millions more are at increased risk and may not even know it. On World
Kidney Day, Fresenius
Medical Care North America (FMCNA), the nation’s leading network of dialysis
facilities, encourages those at risk for CKD to more...
3/8/11 3:02 am EST
BAD HOMBURG, Germany--(BUSINESS WIRE)--Fresenius Medical Care AG & Co. KGaA (“the company” or “Fresenius
Medical Care”), the world’s largest provider of dialysis products and
services, today announced the acquisition of all assets of Hema Metrics
LLC related to its Crit-Line® system. Based on its strong
dialysis product business and sales organization, Fresenius Medical Care
intends to establish this technology as the standard of care for fluid
and more...
2/28/11 1:02 pm EST
Maintaining a healthy diet is a goal for many people, but for those with
chronic illnesses it can be a matter of life and death. During National
Kidney Month this March, Fresenius
Medical Care North America (FMCNA), the nation’s leading network of dialysis
facilities, is partnering with celebrity Chef Aaron
McCargo, Jr., star of Food Network’s “Big Daddy’s House,” to promote
healthy diets that include tasty, satisfying meals for people with more...
2/25/11 8:31 am EST
Fresenius Medical Care AG & Co. KGaA (“the company” or “Fresenius
Medical Care”), the world’s largest provider of dialysis products and
services, today announced that it has filed the annual report 2010 under
Form 20-F with the U.S. Securities and Exchange Commission (SEC). The
report is available at the company’s website www.fmc-ag.com
in the “Investor Relations” section as well as at the SEC's website, www.sec.gov.
A hard copy of more...
2/23/11 1:54 am EST
Fresenius Medical Care AG & Co. KGaA (NYSE: FMS) (FWB: FME):
4th
Quarter 2010 Summary:
Net revenue
$3,167 million more...
2/20/11 4:17 pm EST
WALTHAM, Mass.--(BUSINESS WIRE)--Fresenius Medical Care (NYSE: FMS), the world’s leading company devoted
to patient-oriented renal therapy, announced today that the U.S. Food
and Drug Administration (FDA) cleared its 2008K@home™ dialysis machine.
Specifically designed to facilitate hemodialysis treatment in the home
environment, the newly approved device offers many patients more options
for achieving adequate dialysis in the comfort of their own home more...
1/27/11 9:00 am EST
Patient advocate and triathlete Shad
Ireland will help raise awareness of patients on dialysis
for 25 years or more by visiting a select group of clinics across the
U.S. over the next two months. Ireland is a national spokesman for Fresenius
Medical Care North America (FMCNA), the nation’s leading network of dialysis
facilities, which annually recognizes its 25-year patients with the
Quarter Century Patient Recognition Program. Ireland’s visits more...
1/27/11 6:57 am EST
Fresenius Medical Care AG & Co. KGaA (“the company” or “Fresenius
Medical Care”), the world’s largest provider of dialysis products and
services, today announced the pricing of US$-denominated and
€-denominated senior unsecured notes (together “the senior notes”) in
the principal amounts of US$650 million and €300 million, respectively,
both due 2021. The principal amount of the US$ senior notes was
increased from the amount initially more...
1/21/11 4:17 am EST
Fresenius Medical Care AG & Co. KGaA (“the company” or “Fresenius
Medical Care”), the world’s largest provider of dialysis products and
services, today announced its intention to sell US$500 million of senior
unsecured notes due 2021 issued by Fresenius Medical Care US Finance,
Inc. and €300 million of senior unsecured notes due 2021 issued by FMC
Finance VII S.A. (together with the US$ senior notes “the senior
notes”). Both issuers are more...
1/19/11 8:11 am EST
Fresenius Medical Care AG & Co. KGaA (“the Company” or “Fresenius
Medical Care”; Frankfurt Stock Exchange: FME / New York Stock Exchange:
FMS), the world’s largest provider of dialysis products and services,
today announced a cooperation agreement with the public health
authorities in the Murcia region of Spain for the country’s first
comprehensive dialysis care and performance-oriented reimbursement
model. Under this agreement, Fresenius more...
1/17/11 9:30 am EST
Results from the Centers for Medicaid and Medicare Services (CMS) End
Stage Renal Disease (ESRD) Disease Management Demonstration Project have
been presented by the independent evaluation contractor, Arbor Research
Collaborative for Health, in a series of scientific abstracts and a
comprehensive evaluation report. The ESRD DM Demonstration Project is a
five-year demonstration project (2006 to 2010) conducted by CMS to test
the impact of expanded more...
1/14/11 11:23 pm EST
Fresenius Medical Care North America (FMCNA) has announced a voluntary
recall of specific lots of CombiSet True Flow Series™Hemodialysis
Blood Tubing Set with Priming Set and Transducer Protectors (Part
Numbers 03-2695-9 and 03-2795-7) for use with the Blood Volume Monitor
(BVM), due to reports of arterial line kinks. The kinking may develop
prior to or during use and may not be apparent until after the blood
tubing warms. The most commonly more...
1/4/11 11:20 am EST
Fresenius Medical Care AG & Co. KGaA (the “Company” or “Fresenius
Medical Care”) (FWB: FME) (NYSE: FMS), the world’s largest provider of
dialysis products and services, today announced the signing of a
purchase agreement to acquire International Dialysis Centers (“IDC”),
Euromedic International’s (“Euromedic”) dialysis service business.
Euromedic has decided to prioritize its investments in the diagnostics
and cancer treatment fields. more...
12/20/10 6:34 pm EST
The first major snowstorm of 2010 brought blizzards and sub-zero
temperatures that created hazardous driving conditions and other
disruptions in communities across the Midwest. People on dialysis
typically need treatment every two to three days, so they are
particularly vulnerable when inclement weather knocks out electricity or
makes travel to their clinics difficult. Any delays in treatment can be
life threatening, so it's important for more...
12/1/10 11:59 am EST
Fresenius Medical Care AG & Co. KGaA (“FMC AG & Co. KGaA”) (FWB: FME)
(NYSE: FMS), the world’s largest provider of dialysis products and
services, and Galenica Ltd. (“Galenica”) today announced the formation
of a new renal pharmaceutical company (Vifor-Fresenius Medical Care
Renal Pharma Ltd.) designed to develop and distribute on a worldwide
basis products to treat iron deficiency anaemia and bone mineral
metabolism for pre-dialysis and more...
11/15/10 3:38 pm EST
Fresenius
Medical Care North America (FMCNA), the nation’s leading provider of
kidney dialysis clinics and renal products, is presenting research
abstracts about dialysis treatment, patient care and outcomes during the American
Society of Nephrology’s (ASN) annual meeting, Renal
Week 2010, the largest scientific gathering of kidney disease experts
worldwide.
Renal Week takes place Nov. 16–21 in Denver. This year’s theme is more...
11/12/10 11:02 am EST
The American
Association of Kidney Patients (AAKP), which for more than 40 years
has championed the cause of improving the lives of fellow kidney
patients, is honored to partner with Fresenius
Medical Care North America (FMCNA), the nation’s leading network of
dialysis facilities, in its Quarter Century Patient Recognition Program.
The program recognizes FMCNA patients who have been on dialysis for 25
years or more.
“This more...
11/2/10 6:52 am EDT
Fresenius Medical Care AG & Co. KGaA (FWB:FME)(NYSE:FMS):
3rd
Quarter 2010 Summary:
Net revenue
$ 3,058 million
+ 6 more...
10/28/10 10:51 am EDT
You might not expect a health care company to be expert in disaster
preparedness. But Fresenius
Medical Care North America (FMCNA) knows that kidney dialysis
patients need treatments every two to three days to survive, and they
can’t wait for treatment and supplies until the wreckage and debris are
cleared after a storm.
As the world’s largest vertically integrated provider of dialysis
products and services, FMCNA has a more...
10/4/10 8:00 am EDT
Beginning in mid-October, Fresenius Medical Care North America will
offer all of its patients and clinical staff an annual flu vaccine,
which protects against both seasonal flu and H1N1 this year. The Centers
for Disease Control (CDC) cautions that it is likely that H1N1 will
continue to spread along with seasonal viruses this flu season.
Fresenius
Medical Care North America (FMCNA), the nation’s leading network of dialysis more...
10/1/10 11:40 am EDT
Fresenius Medical Care AG & Co. KGaA (the company or FMC AG & Co. KGaA;
Frankfurt Stock Exchange: FME / New York Stock Exchange: FMS), the
world’s largest provider of dialysis products and services, today
announced successful completion of the upsizing and extension of its
senior secured credit facility. The refinancing of the revolving
facility and Term Loan A was well received with a substantial
oversubscription and enabled the company more...
8/26/10 10:27 am EDT
Fresenius Medical Care AG & Co. KGaA (FWB: FME) (NYSE: FMS), the world’s
largest provider of dialysis products and services, today announced that
it has signed an agreement to acquire Gambro’s worldwide peritoneal
dialysis (PD) business. Gambro has decided to prioritize its investments
in the hemodialysis field. Fresenius Medical Care is taking advantage of
this opportunity to expand its activities in the homecare market,
especially in more...
8/17/10 1:35 pm EDT
Most dialysis
patients receive life-sustaining therapy at a clinic near their home
three days a week. Traveling away from home was a challenge in the past,
but today it’s easy to arrange for dialysis at a clinic near their
destination. Fresenius
Medical Care North America (FMCNA) wants to encourage all dialysis
patients, whether they are FMCNA patients or not, to enjoy travel and
take vacations across the U.S. and abroad by utilizing its more...
8/9/10 1:00 pm EDT
Fresenius
Medical Care North America (FMCNA), a subsidiary of the world's
largest provider of dialysis therapy services and products, is pleased
to honor Marion Smith, R.N., as the winner of the Ernestine M. Lowrie
Award for Clinical Excellence. The award is presented in remembrance of
Ernestine M. Lowrie, R.N., who laid the foundation for nursing
leadership and patient care at FMCNA, and helped establish the company's
outpatient dialysis more...
8/3/10 10:56 am EDT
Fresenius Medical Care AG & Co. KGaA (NYSE:FMS)(FWB:FME):
2nd
Quarter 2010 Summary:
Net revenue
$ 2,946 million
+ 7%
Operating income (EBIT more...
7/23/10 11:18 am EDT
Fresenius Medical Care AG & Co. KGaA (“the company”) (NYSE: FMS) (FWB:
FME), the world’s largest provider of dialysis products and services,
has entered into a long-term, 10-year exclusive distribution agreement
with Japanese-based Nikkiso Co. Ltd. for hemodialysis and peritoneal
dialysis products in Japan. With this agreement, both companies aim to
further expand their market share of dialysis products, particularly
dialyzers and peritoneal more...
6/30/10 7:24 am EDT
Fresenius Medical Care AG & Co. KGaA (“the company”) (FWB: FME) (NYSE:
FMS), the world’s largest provider of dialysis products and services, is
expanding its dialysis services business in the Russian Federation. The
company announced today that it has signed an agreement to acquire KNC
(KRAEVOY NEFROLOGICHESKIY CENTR), a private operator of dialysis clinics
in Russia’s Krasnodar region. The acquired operations will add
approximately $25 more...
Copyright© 2006- Fresenius Medical Care Holdings, Inc. All rights reserved. Terms of Use